Expedited a pharma brands journey to blockbuster status in primary care space
Global Pharma
Brand Positioning
Client Context And Challenges
The client asked for a team of consultants to support expediting the product launch activities, when one of their not-differentiated medications achieved significant cardiovascular benefits and became one of the most innovative medication at the time.
This meant a brand new positioning, targeting, messaging, and overall a brand new launch within the context of competitors potentially releasing similar results within an 18 month window
Requiring the launch to be significantly expedited while handling complications arising from an alliance set-up
Our Approach
With a team of 4 consultants, we tackled the situation through 14 different workstreams
Managed cross-workstream interdependencies seamlessly to win much-needed time;
Improved strategic decision making by increasing transparency and analytical decision support
Carefully handled corporate, regional, and alliance stakeholder engagement to drive timely decisions to enable execution
Impact We Achieved
A very successful launch within 9 months from original data read-out
A brand that has achieved blockbuster status within 15 months
Three new indication studies (since then successfully completed) fully funded